Quest Laboratories

Quest Laboratories Book Value per Share

The Book Value per Share of Quest Laboratories (QUESTLAB.NS) as of Nov 20, 2026 is 49.91 INR. In the previous year, Book Value per Share was 17.48 INR — a change of 185.60% (higher).

Book Value per Share

49.91INR

YoY

185.60%

Last updated:

Book Value per Share of Quest Laboratories is 2025 49.91 INR. Book Value per Share of Quest Laboratories was 2024 17.48 INR. It decreases by 185.60% higher compared to the previous year.

The Quest Laboratories Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2023
9.17 INR
Jan 1, 2024
17.48 INR
Jan 1, 2025
49.91 INR
The Quest Laboratories Book Value per Share history
YEARBook Value per ShareYoY
49.91INR+185.60%
17.48INR+90.67%
9.17INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quest Laboratories Stock analysis

What does Quest Laboratories do? Quest Laboratories Ltd generates revenue through the manufacturing and sale of pharmaceutical formulations, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, and antidepressants. The company produces ethical drugs, generic drugs, and over-the-counter (OTC) products available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. Key products include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, and Silver Sulphadiazine Cream IP, which are sold to healthcare providers and consumers through distribution networks. The company targets multiple market segments including hospitals, clinics, pharmacies, and direct consumer channels for its diverse product portfolio. Ethical drugs and generics cater to prescription-based healthcare needs, while OTC products serve self-medication demands. Products like Zinc Oral Solution USP and Alpha Amilase & Pepsine are positioned for specific therapeutic categories, ensuring broad market coverage across India's pharmaceutical landscape. Quest Laboratories Ltd focuses on producing high-quality formulations with standardized dosages and regulatory compliance, leveraging its manufacturing capabilities to serve both institutional and retail markets. The firm's product range spans critical therapeutic areas, enabling it to capture demand from various healthcare stakeholders without relying on external partnerships or third-party brands. Quest Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quest Laboratories stock

Book Value per Share of Quest Laboratories is 49.91 INR in 2025.

Book Value per Share of Quest Laboratories changed from 17.48 INR to 49.91 INR, representing a 185.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Quest Laboratories since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Quest Laboratories

All Key Metrics — Quest Laboratories